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Abstract
This project aims to study  the possible adverse effects of exposure to ultrafine particles, 
which are foreign to the human body have the ability  to induce inflammation. This ability 
makes it relevant to examine how inflammation during pregnancy  can affect the fetus during 
development, both immediately  after birth and later on in life. IL-1β is an important pro-
inflammatory cytokine. Therefore we chose to focus on IL-1β specifically  and assess the 
possibility  of a causal relationship, between an elevated IL-1β level during pregnancy, and 
adverse effects on the immune response and neural development of the offspring exposed in 
utero. The assessment of adverse effects of elevated IL-1β level was achieved through 
examination of relevant studies and by discussing results and setup of these. It is concluded 
that IL-1β can be transferred from mother to fetus and reach the fetal blood and brain. An 
elevated level of IL-1β during fetal development can change the inflammatory response of 
the offspring immediately  after birth, but there are no signs indicating that this change is 
permanent. High levels of IL-1β in the fetal brain can inhibit development of neurons and 
dendrites. There is evidence of causal relationships between an elevated level of IL-1β 
during pregnancy and both altered immune response and neural development of the fetus.
Abstrakt
Dette projekt har til formål at studere de mulige skadelige effekter forårsaget af ultrafine 
partikler. Disse partikler, der er fremmede for kroppen, har en evne til at inducere 
inflammation. Det er derfor relevant at undersøge, hvordan inflammation under graviditeten 
kan påvirke fosterets udvikling, både for den nyfødte samt senere i livet. IL-1β er et vigtigt 
pro-inflammatorisk cytokin. Derfor har vi valgt at fokusere specifikt på IL-1β og undersøge 
den mulige sammenhæng mellem et forhøjet IL-1β niveau under graviditet, og skadelige 
effekter på immunresponsen og den neurale udvikling i afkommet eksponeret in utero. 
Denne vurdering af konsekvenser forårsaget af forhøjet IL-1β niveau er opnået gennem 
studie af relevante undersøgelser og ved at diskutere deres resultater og forsøgsdesign. Det 
er konkluderet, at IL-1β kan overføres fra mor til foster og nå fostrets blod og hjerne. Et 
forhøjet niveau af IL-1β under fostrets udvikling kan ændre den nyfødtes inflammatoriske 
respons, men det tyder ikke på at denne ændring er permanent. Høje niveauer af IL-1β i 
fosterhjernen kan hæmme udviklingen af neuroner og dendritter. Der er tegn på en 
årsagssammenhæng mellem et forhøjet IL-1β niveau under graviditeten og både en ændring 
af immunrespons samt den neurale udvikling i afkom.
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In order to write this project we searched for relevant literature in databases, Google Scholar, 
SCOPUS, Science Citation Index Expanded (SCI), Springerlink, Elsevier ScienceDirect and 
TOXLINE using search words and sentences such as, “interleukin-1beta”, “inflammation in 
pregnant women”, “elevated interleukin-1beta levels in placenta”, “effect of  altered 
interleukin-1beta level on offspring”.
When describing the following studies Surriga et al. (2009) and Lasala & Zhou (2007), 
abbreviations is used for the 4 different offspring groups: saline pre and post birth (S+S), 
saline before and LPS after birth (S+L), LPS before birth and saline post (L+S) and those 
which received LPS before and after birth (L+L).
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1 Introduction
Experimental data shows elevated levels of IL-1β and other pro-inflammatory  cytokines in 
mice as an effect of exposure to different kinds of ultrafine particles. Furthermore the levels 
of cytokines are also known to rise in the placenta of pregnant women when exposed to 
these particles [Jonakait, 2007]. Use of engineered nano particles in the industry  and air 
pollution from traffic, exposure for these small sized particles have increased. Exposure can 
happen through inhalation, ingestion or injection. 
Ultrafine particles in general have a larger surface area per mass unit than larger particles 
with the same properties, therefore potentially  possess increased toxicity compared to 
particles of bigger size [Oberdörster et al., 2005]. Studies have shown that the smaller the 
particles are, the greater a pulmonary inflammation they induce when mice are exposed for 
the same mass of different sized particles. Furthermore, nano particles of different 
composition have been shown to cause reactive oxygen species (ROS) [Oberdörster et al., 
2005]. Inhaled particles might enter the blood and lymphatic circulation. The ability  of the 
particles to be transferred to the blood depends of their surface and size. Once in the blood 
they can be distributed throughout the body [Oberdörster et al., 2005]. 
The ability  of ultrafine particles to induce inflammation in mammals and raise the levels of 
cytokines in the placenta of pregnant women, leads to the question of whether itʼs possible 
that exposure to these particles might affect the development of fetus and possibly  cause 
adverse health effects in the offspring. More precisely; 
What are the effects of an increased level of IL-1β during fetal development, in terms 
of neural development and immune response of offspring later in life?
This problem was examined using relevant literature and by  trying to deduce associations 
between inflammation during pregnancy  and possible adverse or non-adverse effects in the 
offspring. Effects were examined both immediately  after birth and during the life of the 
offspring.
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2 Inflammation in general and inflammation during 
 pregnancy
2.1 Inflammation
Inflammation is an immune response causing redness, heat, swelling and pain. The 
inflammatory response is a cascade of events providing protection against infection or tissue 
injury  [Kuby, 1994]. This response encompasses a lot of different cells, and cytokines play  a 
significant role in the inflammatory response [Goldsby  et al., 2003]. An acute inflammatory 
response has a quick onset and does not last for long, but a persistent immune activation 
can cause a chronic response which is potentially  harmful [Goldsby  et al., 2003]. After tissue 
injury  the diameter of the vessels in the vascular system is increased and an increased 
volume of blood enters the point of injury   [Goldsby  et al., 2003]. White blood cells leave the 
blood and adhere to endothelial cells [Old, 1988], absorb pathogens by phagocytose and 
different mediators contributing to the inflammatory  response are released [Goldsby  et al., 
2003]. Macrophages enter the injured tissue and destroy pathogens [Old, 1988]. 
Chemokines attract macrophages to the site of inflammation. The activated macrophages 
secrete the three cytokines IL-1, TNF-α and IL-6 which induce many  of the changes in the 
acute inflammatory  response [Goldsby  et al., 2003]. The combined action of the cytokines is 
responsible for many of the effects during inflammation [Kuby, 1994]. IL-1 and TNF-α affect 
macrophages and endothelial cells and induce the production of chemokines. All three of the 
cytokines act on the hypothalamus and induce a fever response [Goldsby  et al., 2003], the 
increased temperature inhibits the growth of several pathogens and can enhance the 
immune response [Kuby, 1994].
Interleukin-1 which has a major part in the inflammatory  response. It is a primary  molecule in 
the inflammatory  reactions since it induces other inflammatory  mediators. Microglia is a 
source of IL-1 after damage to the central nervous system (CNS), infection or inflammation 
and astrocytes also produce IL-1. IL-1 is an activator of host defense both within and outside 
CNS [Rothwell, 2000].
IL-1 is composed of IL-1α and IL-1β which have similar biological activity  [Paulesu et al., 
2008], they  can regulate cell growth and facilitate communication between cytokines [Peters, 
1996]. We focus on IL-1β. IL-1β is among others produced by  T and B lymphocytes, brain 
astrocytes and microglial cells [Rothwell, 2000]. 
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2.2 Inflammation during pregnancy
Cytokines have an important role in the development and the maturation of placenta. In the 
normal placenta many immune hormones and cytokines are produced [Sarandakou et al. 
1998] and during the lifetime of the placenta it can produce many  different inflammatory 
stimuli [Mouzon & Guerre-Millo, 2006]. IL-1β is thought to have a significant role in the 
embryogenesis, and also in the development and differentiation of the fetus by  regulating the 
growth and differentiation of tissues and organs [Sarandakou et al., 1998]. IL-1β stimulates 
the hypothalamus to produce human chorionic gonadotrophin (hCG) [Librach et al., 1994], 
and has been shown to stimulate the secretion of corticotropin-releasing hormone (CRH). 
The secretion of CRH induces secretion of adrenocorticotropic hormone (ACTH) by  human 
placenta [Bowen et al., 2002], [Librach et al., 1994], [Horai et al.,1998]. A widely  supported 
hypothesis is that many of these factors produced by the placenta contribute to the regulation 
of immune changes which are needed for a successful pregnancy [Sarandakou et al., 1998].
IL-1β is hypothesized to have a role in signaling the onset of labor [Bowen et al., 2002], while 
at this point the level of IL-1β is elevated and reflects a systemic reaction in the mother which 
could be the signal of labor [Sarandakou et al., 1998]. It has been indicated that 
concentrations of inflammatory  cytokines increase with increased gestational age [Bowen et 
al., 2002]. Sarandakou et al. (1998) found elevated values of inflammatory  cytokines, IL-1β 
among others, in healthy newborn infants compared to the levels of the umbilical cord and 
maternal serum. This indicate a possible involvement in immune response to the stress of 
delivery. The levels were highest at the first day  after birth and declined in the following days 
[Sarandakou et al., 1998]. The innate immune response develops during the fetal life and 
neonatal period, but maturation is not achieved until months after birth [Belooseky  et al., 
2010]. 
The placenta is an immunological barrier between maternal and fetal antigens [Sarandakou 
et al., 1998]. Lipopolysaccharides (LPS) and other inflammatory mediators may cross the 
placenta and initiate a cascade of events that results in fetal oxidative stress, which is 
thought to play  an important role in the capability  of the offspring to cope with the current 
environment [Belooseky et al., 2010]. Cytokine imbalance and elevated expression of pro-
inflammatory molecules have been found in preeclamptic placentas, among these an 
elevated production of IL-1 [Rusterholz et al., 2007].
When pregnant women are exposed to ultrafine particles, pro-inflammatory  cytokines are 
elevated, including the levels of cytokines in placenta [Jonakait, 2007]. 
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3 Which factors can cause changes in the level of 
 IL-1β?
Results from different studies have shown that elevated IL-1β due to inflammation induce 
elevated IL-1β in the offspring. IL-1β is a pro-inflammatory  cytokine which is commonly used 
as an indicator of inflammation, along with other pro-inflammatory  cytokines such as IL-1α, 
TNF-α and IL-6. Thus, to test the effects of an induced elevation in the IL-1β levels, the level 
change is often induced by  the use of substances that trigger an inflammatory  response. 
Widely  used are lipopolysaccharides (LPS), from Gram-negative bacteria and act as an 
endotoxin, to induce strong inflammatory  responses in mammals. As previously  mentioned 
(see chapter 1) there are several inflammatory inducers in our environment. Malek et al. 
(2001) investigated the effects of LPS, oxidative stress and hypoxia on inflammatory 
cytokines (IL-1α, IL-1β, TNF-α and IL-6) and prostaglandins (8-iso-PGF2α/6-keto-PGF1α and 
TXB2) in vitro. Human placental explants were exposed to air environment containing 2 % 
O2, 5 % CO2 and 93 %  N2 (hypoxia), xanthine + the enzyme xanthine oxidase (inducing 
oxidative stress) and LPS. Cytokine and prostaglandin levels were measured using ELISA 
assays [Malek et al., 2001]. The results showed significantly  elevated levels of IL-1β in all 
cases, hypoxia (P<0.01), oxidative stress and LPS (both P<0.001) as shown in 
figure 1.
Hypoxia can be caused by  sleep apnea, hypopnea, staying at high altitude or by  breathing 
gas mixtures with a low content of oxygen. Oxidative stress is caused by  a long term 
condition of elevated levels of Reactive Oxygen Species (ROS) in the cells. ROS are 
generated during oxidative phosphorylation and also by the immune system for killing 
pathogens. It is of high importance that ROS will be converted quickly  before it, due to the 
high reactivity, can conduct damage on enzymes, membranes and nuclear DNA. This can 
result in mutations that might damage the functionality  of the cells or even cause cancer. In 
summary, several factors can cause an elevated level of IL-1β in the mother. 
Figure 1. Elevated levels of IL-1β in 
p lacen ta l exp lan ts under the 
conditions of hypoxia, oxidative 
stress (X  + XO) and exposure to LPS, 
with or without  nimesulid (NS-398) or 
indomethacin (IM).
Levels of IL-1β were measured in 
placental explants using ELISA assays. 
All results were significant compared to 
controls. ** (P<0.01). *** (P<0.001) 
[Malek et al., 2001]
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4 An elevated level of IL-1β in utero and the effect 
 on the immune response of the offspring
In order to elucidate what consequences an elevated maternal level of IL-1β during 
pregnancy  can have, the impact of maternal inflammation on the immune response of the 
offspring has been the subject of several studies.
4.1 Prenatal LPS exposure and the effects on postnatal immune response 
 towards LPS
By stimulating the immune system of pregnant mice Surriga et al. (2009) studied the effects 
on the hepatic inflammatory  response in the offspring. The pups were randomly  divided after 
birth which gave 4 different offspring groups: saline pre and post birth (S+S), saline before 
and LPS after birth (S+L), LPS before birth and saline post (L+S) and those which received 
LPS before and after birth (L+L). Dams received a saline injection or 500 μg/kg bodyweight 
(bw) LPS, respectively, on day  18 of pregnancy. On day  21 after birth pups received a saline 
injection or 250 μg/kg bw LPS injection. 2 hours after injection 5 rats from each group  were 
euthanized and liver tissue was harvested for semi quantitative reverse transcriptase-
polymerase chain reaction (RT-PCR) assay, in which the levels of cytokines IL-1β, TNF-α 
and IL-6 were determined [Surriga et al., 2009].  The IL-1β levels of both S+L and L+L 
groups raised significantly compared to S+S and L+S groups, as it would be expected due to 
the known effect of LPS. It is noteworthy  that only  the level of IL-6 changed significantly 
comparing S+L and L+L [Surriga et al., 2009]. According to Surriga et al. (2009) it is likely 
that this altered cytokine exposure during fetal development can affect the hepatic 
maturation, and thus the hepatic inflammatory  response [Surriga et al., 2009]. The results are 
shown in figure 2.
Figure 2. Relative mRNA levels of IL-1β  and IL-6 in pups, measured using RT-PCR assay at day 21 after 
birth. 
Saline treated pups from saline treated dams (S+S), LPS treated pups from saline treated dams (S+L), saline 
treated pups from LPS treated dams (L+S) and LPS treated pups from LPS treated dams (L+L). * denotes 
significant  difference from S+S group (P<0.05), & denotes significant difference from L+S group  (P<0.05) and # 
denotes significant difference from S+L group (P<0.05), all levels were normalized to β-actin [Surriga et al., 
2009].
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Lasala & Zhou (2007) made similar experiments to study  how the inflammation in pregnant 
rats may  have impact on the offspring's inflammatory  response after birth. The pregnant mice 
were randomly  divided in two groups. On day  18 of gestation (E18) they  received 500 μg/kg 
bw LPS or a saline injection. On day 1 or day 21 after birth the pups received a 250 μg/kg bw 
LPS injection or saline injection, and were euthanized 2 hours after injection. No results from 
day 1 were significant, and that they  are not presented in Lasala & Zhou (2007). A possible 
explanation given is that the immune system is not fully  developed at such an early  time 
point in life [Lasala & Zhou, 2007]. Trunk blood was used for enzyme-linked immunosorbent 
assay (ELISA), to estimate the cytokine level, and from each pup the brain were dissected 
and used for RT-PCR (see section 5.1). 
The results of ELISA from Lasala & Zhou (2007) are shown in figure 3. The blood serum 
levels of all cytokines (TNF-α, IL-6 and IL-1β) measured using ELISA at day  21 after birth 
(P21), were significantly  lower in L+L pups than in S+L pups [Lasala & Zhou, 2007]. This 
indicates that the immune response in general induced by  LPS, was lowered on day  21 after 
birth, if the pups had been exposed to LPS via their mother before birth. Fetuses exposed for 
elevated IL-1β levels in utero, had lower immune response on day  21 after birth compared to 
offspring which had not been exposed. Furthermore, out of the 22 dams receiving LPS, 11 
dams had fetal reabsorption and 2 gave birth to only  stillborn pups. They  also conclude that 
E18 seems to represent an important developmental period, due to the observed significant 
impact on the development of the immune response of the offspring [Lasala & Zhou, 2007].
In summary, LPS is an efficient inducer of inflammation and is broadly  used in experiments 
where inflammation is wanted. LPS exposure of mother at E18 and re-exposure of offspring 
at P21 in two different studies, Surriga et al. (2009) and Lasala & Zhou (2007) showed 
different results of L+L groups compared with saline exposure of mother at E18 and LPS 
exposure of offspring at P21, regarding change in the levels of IL-1β. Surriga et al. (2009) 
saw no significant difference between the two groups in liver tissue, whereas Lasala & Zhou 
Figure 3. The  blood serum levels of 
IL-1β in offspring from mothers 
treated with injection of 500 μg/kg 
LPS on day 18 of pregnancy. 
Subsequently postnatal treated with 
saline or 250 μg/kg LPS.
Saline treated pups from saline treated 
dams (S+S), LPS treated pups from 
saline treated dams (S+L), saline treated 
pups from LPS treated dams (L+S) and 
LPS treated pups from LPS treated dams 
(L+L). * denotes significant difference 
from S+S. # denotes significant 
difference from L+S. & denotes 
significant difference from S+L [Lasala & 
Zhou, 2007].
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(2007) showed significantly  lower levels of IL-1β in the blood of pups who had been both 
prenatally and postnatally exposed to LPS.
Comparing Lasala & Zhou (2007) to Surriga et al. (2009) both studies found elevated levels 
of IL-1β in S+L and L+L compared with S+S and L+S, as expected due to the known effects 
of LPS. But of the two studies only  Lasala & Zhou (2007) found significantly  lower levels in L
+L compared to S+L of all 3 cytokines measured. 
4.2 Prenatal LPS exposure and altered immune response towards LPS of 
 offspring during life
Hodyl et al. (2007) have performed a modified study  to clarify how prenatal exposure to LPS 
can cause altered immune responses during life. 4 time points (19 days, 7 weeks, 3 months 
or 13 months) in the life of the rat offspring were chosen to characterize the immune 
response. Pregnant rats received subcutaneous LPS injections 200 μg/kg bw or saline, 3 
times during pregnancy (on day 16, 18 and 20) [Hodyl et al., 2007]. 
The pups treated at the time points 19 days and 7 weeks received 50 μg/kg bw LPS 
injections, and at 3 months and 13 months old the pups received 100 μg/kg bw. Pups were 
either decapitated at baseline (without postnatal exposure) or 4 hours after LPS exposure. 
Both control pups and prenatally  exposed pups received LPS injection. Blood from the 
decapitated pups was collected and used for cell count and ELISA assays for determination 
of cytokine levels [Hodyl et al., 2007].
At the time point 19 days (see figure 4) the control offspring had significantly  higher IL-1β 
levels 4 hours after treatment compared to the levels at 0 hours, but the pups exposed to 
LPS did not have an elevated IL-1β levels from 0 hours to 4 hours. At 7 weeks Hodyl et al. 
found significantly  elevated IL-1β levels at 4 hours in both the control and the prenatal LPS 
treated pups. The 3 months old pups had a significantly higher IL-1β level after 4h in both the 
control and the LPS pups. Also at 13 months the IL-1β level was significantly  elevated at 4 h 
in both the control and LPS exposed pups, compared to baseline [Hodyl et al., 2007].
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The results at 19 days shows no significant change of the IL-1β level of prenatally  exposed 
pups compared to controls, without postnatal LPS treatment. At the latest time points (7 
weeks, 3 months and 13 months) the level at 0h is low and a significant activation of the 
immune system is seen, suggesting that the prenatal exposure does not cause permanent 
alterations on the immune response [Hodyl et al., 2007].
Hodyl et al. (2007) also show lowered levels of IL-1β in prenatally  exposed pups with 
postnatal LPS treatment, similar to the results of Surriga et al. (2009) and Lasala & Zhou 
(2007).
4.3 Exposure of IL-1β only, at different stages of development
Bäckström et al. (2010) used a transgenic mice model to examine the effect on pups 
exposed to a raised IL-1β level in dams during pregnancy. By generating bi-transgenic (bi-
TG)dams  it was possible to induce production of IL-1β using doxycycline. Doxycycline is an 
antibiotic which binds to the promoter, and thereby  inducing IL-1β expression. A two-
component genomic system consisting of CCSP-rtTA+/+ activator transgenes, expressing 
rtTA controlled by  the Clara cell secretory  protein (CCSP) promoter, and (tetO)7CMV-hIL-1β 
in which expression of human IL-1β (hIL-1β) is driven by  the tetracycline-responsive 
promoter (tetO)7CMV, responding to doxycycline was used [Bäckström et al., 2010]. In this 
Figure 4. Levels of IL-1β in 
blood serum of offspring at 
time points, 19 days, 7 
weeks, 3 months and 13 
months. Measured using 
ELISA.
Blood serum levels  of IL-1β at 
4 different time points in the 
offspring's life. Controls in 
black have not previously 
been exposed to endotoxin. 
Grey columns have been 
p r e n a t a l l y e x p o s e d t o 
endotoxin 3 times, 16, 18 and 
20 days into pregnancy. 
Columns in the left were 
measured without postnatal 
exposure to LPS. Columns in 
the right were measured 4 
hours after postnatal exposure 
to LPS. * denotes significant 
difference, (P<0.01) in 19 
days, (P=0.018) in 7 weeks. # 
denotes significant difference 
(P<0.001) in 3 months and in 
13 months [Hodyl et  al., 
2007].
IL-1β level at 19 days                          IL-1β level after 7 weeks
0h left, 4h right                                    0h left, 4h right
IL-1β levels at 3 months                    IL-1β level at 13 months;
0h left, 4h right                                     0h left, 4h right
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way  it was possible to study  the effect of IL-1β The principle of the experimental setup is 
illustrated in figure 5.
All dams were given doxycycline but were not able to express IL-1β. All dams were given 
500 μg/ml doxycycline in drinking water, either from embryonic day  0 (E0) or from E15 to 
postnatal day  7 (P7). But controls were not able to express IL-1β. The CCSP promoter is not 
active in the fetus until E14. The elevated maternal hIL-1β level induced expression of 
murine IL-1β (mIL-1β) in the lungs of the pups, which was measured using RT-PCR on RNA 
from lung tissue [Bäckström et al., 2010]. Results showed significant difference in the levels 
of mIL-1β. Exposure from E0 significantly  lowered the IL-1β in the bi-TG pups of bi-TG 
mothers compared to the bi-TG pups from control mothers. This shows that maternal IL-1β 
production, before E14, modifies the response of the offspring compared to exposure from 
E15. In  E15 exposed dams, the IL-1β level in the offspring is significantly  higher in the bi-TG 
pups of bi-TG mothers compared to the same pups from E0. This indicates that the time of 
maternal inflammation has impact on the immune response of the newborn, and that an early 
exposure can somehow prepare the inflammatory  response of the offspring [Bäckström et 
al., 2010]. 
Figure 5. Illustration of the generation of bi-TG pups. 
Control mice have only the Clara cell secretory protein (CCSP) promoter and the transactivator rtTA but miss the 
tetracycline-responsive promoter (tetO)7CMV which drive the expression of hIL-1β. The bitransgenic mice have 
the promoter, the transactivator and the operator. Therefore if both the control and the bitransgenic mice are 
exposed to doxycycline, only the bitransgenic mice generate IL-1β [Own figure].
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In order to study  the hypothesis that maternal IL-1β production, prenatally, can prevent lung 
injuries in the offspring postnatally, Bäckström et al. (2010) also examined several other 
effects. The effect of maternal hIL-1β expression on growth and survival of the offspring, as 
well as the influence of maternal hIL-1β expression on postnatal lung morphogenesis was 
also examined. It was concluded that maternal inflammation can protect the newborn 
offspring against hIL-1β-induced lung inflammation and injury [Bäckström et al., 2010]. 
In summary, the time of exposure may  be of importance and exposure had higher impact at 
the early  stages of development where the fetus could not produce IL-1β. Exposure of the 
embryo to maternal IL-1β only, has a noteworthy  impact. It is suggested that the lowered 
immune response as an effect of prenatal exposure to IL-1β may  actually  protect the 
offspring against some pulmonary diseases [Bäckström et al., 2010].
Figur 6: Level of mouse  IL-1β (mIL-1β) 
expressed in pups of bitransgenic dams 
(bi-TG) and pups of control dams, both 
given doxycycline  either from E0 to E14 
or from E15 to P0.
White bars, control pups of  respective 
dams. Grey bars, bi-TG pups of respective 
dams. IL-1β levels were measured after 7 
days of postnatal exposure of  all pups to 
doxycycline in drinking water (500 μg/kg 
bw, P0 to P7), using RT-PCR.
*** denotes significant difference (P<0.001) 
of bi-TG pups (grey bars) compared to 
control pups (white bars). 
†† denotes significant difference (P<0.01) 
compared with bi-TG pups of bi-TG dams 
given doxycycline from E0 [Bäckström et 
al., 2010].
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5 An elevated level of IL-1β in utero and the effect 
 on the neural development of the offspring
Studies have shown that IL-1β can cross the blood-brain-barrier (BBB) and thereby  induce 
production of IL-1β in the brain [Lasala & Zhou, 2007]. Thus, it is relevant to examine the 
possible effects of an elevated level of IL-1β in the brain of the fetus. Several studies have 
examined this.
5.1 Prenatal LPS exposure and IL-1β levels in the brains of the offspring
Lasala & Zhou (2007) studied the effect of LPS on rat brain tissue, in vivo. After exposing 
pregnant dams to either saline or LPS (500 μg/kg bw) on E18. Pups received postnatal intra 
peritoneally  (i.p.) injections of either saline or LPS (250 μg/kg bw) on P21, pups were 
dissected 2 hours later and brains were dissected. RT-PCR analysis was performed and 
IL-1β levels were measured using ELISA. Pups from S+L and L+L groups had significantly 
elevated levels of IL-1β in brain tissue compared to groups S+S and L+S. The level of IL-1β 
in L+L pups was also significantly  lower than in S+L pups. These results indicate that the 
maternal inflammation also has an impact on the brain of the offspring and that cytokines 
may be able to cross the blood-brain-barriere [Lasala & Zhou, 2007]. Results for IL-1β levels 
in brains were similar to the tendency  in IL-1β levels in the blood. That is, levels were 
significantly  lower in postnatally  LPS exposed pups of prenatally  LPS exposed dams, 
compared to LPS exposed pups of prenatally  saline exposed dams. The relative levels of 
TNF-α, IL-1β and IL-6 (normalized to β-actin) in the brains of L+L pups were significantly 
lower than in S+L pups [Lasala & Zhou, 2007].
Graciarena et al. (2010) studied the impact of prenatal inflammation on neurogenesis in 
offspring. Pregnant mice were injected subcutaneous with saline or LPS (500 μg/kg bw) at 4 
time points (E14, E16, E18 and E20). Whole brains from embryos (E14, 2 hours or 6 hours 
after exposure) and hippocampal coronal sections from pups (P0) were obtained and used 
for RT-PCR. Results showed that IL-1β was significantly  increased in E14 (2 hours) 
Figure 7. Relative  levels of IL-1β in brain 
tissue from pups exposed to saline or LPS 
on P21.
Illustrate the levels of  IL-1β   in the brains of 
offspring from dams exposed to either LPS 
(500 μg/kg bw) or saline on E18, and 
stimulated postnatally with saline or LPS (250 
μg/kg bw) on P21. * denotes significant 
difference from S+S group  (P<0.05), & 
denotes significant difference from S+L group 
(P<0.05) and # denotes significant difference 
from L+S group (P<0.05),  all levels were 
normalized to β-actin [Lasala & Zhou, 2007].
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compared to controls and time point at 6 hours. Also the level of IL-1β were significantly 
higher in P0 compared to controls [Graciarena et al., 2010]. It was suggested that an 
elevated IL-1β level might impair the neurogenesis in adulthood [Graciarena et al. 2010].
Liverman et al. (2006) injected i.p. pregnant mice with saline or LPS (50 μg) at E18. 
Surgically  the pups were delivered at 0.5, 1, 2, 4 or 6 hours after injection and their brains 
were collected. RT-PCR analysis was performed and expression of the IL-1β gene was 
measured. Results showed that the IL-1β gene was significantly  up  regulated at 6 hours, with 
no significant changes seen at earlier time points [Liverman et al., 2006]. 
Urakubo et al. (2001) experimented with low-dose and high-dose LPS. In the low-dose 
experiment, pregnant rats were i.p  injected with saline or LPS (500 μg/kg bw) at E16. The 
rats were sacrificed 2 or 8 hours after injection. Fetuses were removed and the fetal brains 
were dissected. In the high-dose experiment, the pregnant rats received LPS i.p. injection 
(2500 μg/kg bw) and were killed 2 hours later. For both experiments the IL-1β level was 
determined using ELISA. The results showed no significant changes in the level of IL-1β in 
the fetal brains, neither in the low-dose or the high-dose experiment [Urakubo et al., 2001]. 
Figure 8a. Relative  levels of IL-1β  in brain tissue from fetuses 
exposed to saline or LPS and measured on E14.
Illustrate the relative levels of IL-1β in the brains of offspring from 
dams exposed to either LPS (500 μg/kg bw) or saline at E14,  2 
hours and 6 hours after exposure. * denotes significant difference 
from controls (P<0.05), all levels were normalized to β-2 
microglobulin [Graciarena et al., 2010].
Figure 8b. Relative levels of IL-1β  in brain tissue from pups 
exposed to saline or LPS at  E14, E16, E18 and E20, measured 
on P0.
Illustrate the relative levels of  IL-1β   in the brains of  offspring from 
dams exposed to either LPS (500 μg/kg bw) or saline at  time 
points  E14, E16, E18 and E20. ** denotes significant difference 
from controls (P<0.01), all levels were normalized to β-2 
microglobulin [Graciarena et al., 2010].
Figure 9. Up regulation of the 
IL-1β gene  in pups 6 hours after 
exposure of dam at E18. 
Shows significant up regulation of 
the IL-1β gene in fetus 6 hours after 
LPS exposure (50 μg/kg bw) of dam 
at E18. * denotes significant 
difference compared to control 
(P<0.05) [Liverman et al., 2006].
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However, IL-1β levels in placenta was also estimated, and 8 hours after injection of the low 
dose a significant increase in IL-1β was observed [Urakubo et al., 2001]. 
Prenatal LPS exposure of the dam raised the IL-1β levels in the brains of the fetus without 
postnatal LPS exposure, both before and immediately  after birth. Liverman et al. (2006) 
showed significant up regulation of the IL-1β gene in brains of pups at 6 hours after LPS 
exposure of the dam compared to other time points. In contradiction Urakubo et al. (2001) 
saw no significant difference in IL-1β levels of brains, in neither low nor high dose 
experiments with LPS.
5.2 Effects on brain development of the offspring
Gilmore et al. (2004) has studied brain tissue from rats in vitro, without prenatal LPS 
exposure. The effect of IL-1β on the development of dendrites in embryonic cortical neurons 
was studied. Brains from embryos at E18 were used. The frontal cerebral cortex was 
dissected from the whole brain and neuronal cells were isolated. After 4 hours the cells were 
treated with 0, 100 or 1000 U/ml IL-1β or IL-1β combined with TNF-α (IL-1β/TNF-α) for 44 
hours. 100 U/ml is approximately 1666 pg/ml [Gilmore et al., 2004]. 
At 100 U/ml there was no significant effect neither on the number of dendrites and nodes or 
on the total dendrite length and neuron survival. At 1000 U/ml a significantly  reduced number 
of primary  dendrites and nodes were observed, also the total dendrite length on cortical 
Figure 10a. The IL-1β  level in the fetal brain 2 
hours and 8 hours after saline  or 500 μg/kg bw 
maternal LPS injection.  
Shows the IL-1β  levels on embryonic day 16 in 
the fetal brains 2 or 8 hours after maternal 
injection of  saline (grey column) or 500 μg/kg 
LPS. No significant elevation of the IL-1β level 
between the controls and the pre-exposed pups is 
detected [Urakubo et al. 2001].
Figure 10b. The IL-1β in the  fetal brain 2 hours 
after maternal injection of saline or 2500 μg/kg 
bw LPS. 
Shows the IL-1β  level in the fetal brain at 
embryonic day 16, 2h after maternal  injection of 
saline (grey column) or 2500 μg/kg bw LPS. 
[Urakubo et al. 2001].
18
neurons were reduced. A decrease in neuronal survival was observed, too (see figure 11a, 
11b and 11c). The results show that IL-1β can inhibit development of dendrites in the 
embryonic cortical neurons significantly  at 1000 U/ml. A synergistic effect between IL-1β and 
TNF-α is also suggested [Gilmore et al. 2004]. This effect of IL-1β  on the development of 
neurons suggest an elevated level could play  a role in the development of schizophrenia 
[Gilmore et al. 2004].
Marx et al. (2001) studied the effect of pro-inflammatory cytokines on the embryonic neuronal 
survival on MAP-2 stained rat embryo in vitro. A MAP-2 antibody is a marker for neuronal 
cells in tissue. Cells were exposed for 48 hours and immunostained. MAP-2 immunostaining 
contribute useful information about the ratio of neuronal survival in the exposed culture 
compared to control cultures. Pregnant rats were killed on E18 and the offspring were 
removed. Brain tissue from pups was treated with IL-1β concentrations 0, 10, 100 or 1000 U/
ml [Marx et al., 2001].
Treatment with 1000 U/ml IL-1β decreased the number of neurons stained with MAP-2 
antibody  compared to control tissue. IL-1β decreased the number of neurons in a dose 
dependent manner, thus the 1000 U/ml treatment decreased the number of neurons to a 
higher degree compared to the 100 U/ml treatments. It was concluded that IL-1β lower the 
number of neurons stained with MAP-2 antibody  in a dose dependent manner, indicating 
Figure 11a. Number of primary dendrites in fetal 
neuronal cells at 44 hours after exposure to 
IL-1β or IL-1β/TNF-α (1000 U/ml), in vitro.
* denotes significant difference compared to control 
(P<0.05), ** denotes significant  difference 
compared to control (P<0.01) [Gilmore et al. 2004].
Figure 11b. Number of nodes in fetal neuronal 
cells  at 44 hours after exposure to IL-1β  or 
IL-1β/TNF-α (1000 U/ml), in vitro.
* denotes significant difference compared to control 
(P<0.05), ** denotes significant  difference 
compared to control (P<0.01) [Gilmore et al. 2004].
Figure 11c. Total length of dendrites in fetal 
neuronal cells  at  44 hours after exposure  to 
IL-1β (1000 U/ml), in vitro.
** denotes significant  difference compared to control 
(P<0.01) [Gilmore et al. 2004].
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decreasing cerebral cortical neuronal survival [Marx et al. 2001]. These results suggest that 
IL-1β has a damaging effect on neuronal survival, and this effect is associated with  the risk 
of schizophrenia [Marx et al., 2001]. 
In summary, studies show that the maternal inflammatory  response can elevate the level of 
IL-1β in the fetal brain. Even though several studies find this correlation, Urakubo et al. 
(2001) does not find an elevated IL-1β level in the brain, though using 5 times the dose 
compared with the other studies. Gilmore et al. (2004) finds that treatment of fetal brain 
tissue with 1000 U/ml IL-1β significantly  reduced the number of primary  dendrites and nodes, 
also the total dendrite length on cortical neurons was reduced. This is suspected to play a 
role in the risk of schizophrenia. Furthermore Marx et al. (2004) supported these findings 
since the study  showed that IL-1β decreased the survival of cerebral cortical neurons in a 
dose-dependent manner. 
Figure 12. Neuron survival after 
treatment with 1, 10, 100 or 1000 
U/ml IL-1β.
After 48 hours exposure of IL-1β  a 
dose-dependent decrease of 
neuron survival was observed. 
* denotes significant difference 
compared with control cultures 
(P<0.01) [Marx et al., 2001].
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Discussion
Several studies have found an elevated level of IL-1β in the offspring following exposure to 
inflammation in utero. Experimentally  induced inflammation in mothers elevated the IL-1β 
level in the blood serum of the offspring. Lasala & Zhou (2007) and Surriga et al. (2009) 
exposed pregnant mice and rats, respectively, both using 500 μg/kg bw LPS on day  18 of 
gestation, and injected the pups on day  21 after birth with 250 μg/kg bw LPS. Surriga et al. 
(2009) estimated the cytokine levels in liver tissue and Lasala & Zhou (2007) used trunk 
blood and brain tissue. Results from both the blood serum and liver tissue showed a different 
response to the postnatal LPS injection depending on whether or not the pups had been 
prenatally  LPS exposed. Prenatal exposure lowered the response to postnatal LPS exposure 
compared to pups without prenatal exposure (section 4.1). This indicates that elevated IL-1β 
levels in the mother during pregnancy  alters the postnatal immune response of the offspring, 
thus subsequent infections cause less immune response. Lasala & Zhou (2007) also 
estimated the cytokine level in pups at P1, but did not get significant results. Furthermore, 
out of the 22 LPS exposed pregnant, 11 of them had fetal reabsorption and 2 of them had 
only  stillborn pups. None of the pregnant control rats experienced any complications [Lasala 
& Zhou, 2007]. Since the rats were injected with LPS nothing specific about IL-1β can be 
concluded, however it is indicated that inflammation during pregnancy can have some 
serious consequences. Surriga et al. (2009) studied the liver tissue since the liver can 
process and clear for LPS, therefore the liver has an important role in the immune system. 
The level of IL-1β in the liver after prenatal LPS exposure was elevated, and this elevation 
might inhibit maturation of the liver.
To study  the importance of the timing of prenatal exposure, Hodyl et al. (2007) LPS exposed 
mice 3 times during pregnancy (E16, E18 and E20 with 200 μg/kg bw). The pups were 
postnatally  either not exposed (0h) or exposed (4h) at 4 selected time points (19 days, 7 
weeks, 3 months and 13 months) during adult life (section 4.2). At the first time point (19 
days) results showed significant elevation of IL-1β levels in controls at 4 hours compared to 
non exposed controls. No significant elevation of IL-1β levels were seen in the prenatally 
exposed pups at 4 hours compared to 0 hours. At the latest time points (7 weeks, 3 months, 
13 months) significantly  elevated IL-1β levels was seen in both controls and prenatally 
exposed pups. This indicates that even though a prenatal exposure towards LPS and pro-
inflammatory cytokines of the fetus can change the response of postnatal LPS-induced 
inflammation, this change is not permanent. This gives rise to some important questions. Are 
the observed changes in immune response of the offspring in early  lifetime merely  just 
caused by  the fact that the immune system is not fully  developed at an early time point? Or is 
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there a chance that this lowered response of the newborn can result in either increased 
sensitivity towards or protection against infections in early life? 
All studies mentioned above have injected LPS, which cause maternal inflammation and 
thereby  initiate the production of several cytokines, including IL-1β. To achieve more specific 
results regarding IL-1β, Bäckström et al. (2010) studied how an elevated maternal IL-1β 
level, exclusively, during fetal development, could affect the offspring (section 4.3). It was 
found that maternal IL-1β exposure of fetuses from E0 (bi-TG pups of bi-TG dams) 
significantly  lowered the production of IL-1β in offspring compared to bi-TG pups of control 
dams. Maternal doxycycline exposure from E15 induced a simultaneous IL-1β production in 
the pups, which resulted in a higher IL-1β. Conclusively, exposure towards maternal IL-1β in 
the early  stage of fetal development might somehow prepare the offspring and cause a 
decreased production of IL-1β in the newborns. This leaves no doubt that the fetus is 
affected by  the IL-1β level of the mother and hence that inflammation during pregnancy can 
affect the production of IL-1β in the offspring, though not necessarily  as a permanent effect. 
Bäckström et al. (2010) points out some beneficial effects of this change in IL-1β production 
of the offspring. A lowered production of cytokines in early  life might help to protect against 
damages from bronchopulmonary dysplasia, as inflammation in newborns can damage the 
lungs. Hence, regulation of IL-1β as an effect of prenatal exposure is not necessarily 
undesirable in the matter of immune response [Bäckström et al., 2010].
Lasala & Zhou (2007) made RT-PCR using brain tissue from LPS exposed pups of LPS 
exposed dams and saline exposed controls, and measured IL-1β levels (section 5.1). Similar 
to results from the blood, IL-1β levels rose significantly  in S+L pups and L+L pups and also 
significantly  lowered levels of L+L pups compared to S+L pups. This indicates that the effects 
of prenatal exposure to maternal IL-1β are parallel in the brain and in the blood. As 
previously  mentioned (chapter 5) the blood-brain-barriere is not fully  developed in early 
stages of life which makes it readily  permeable to cytokines. Thus, correlation of IL-1β levels 
seems to exist between the blood and brain, which makes it possible to assume that 
inflammation in the mother will most likely raise the level of IL-1β in the brain of the offspring. 
In contrast Urakubo et al. (2001) saw no significant changes in the IL-1β levels of fetal 
brains, neither at LPS dose 500 μg/kg bw or 250 μg/kg bw (section 5.1). It is noted that the 
exposure day  was E16, which is different from the time point E18 used by  both Gilmore et al. 
(2004) and Lasala & Zhou (2007) for unspecified reasons. Lasala & Zhou (2007) assess that 
E18 seems to be a period where the offspring is particularly  receptive to the maternal 
inflammation. Urakubo et al. (2001) also estimated the cytokine level in the placenta and 
found a significant increase in the IL-1β level at low  dose at E16, but not until 8 hours after 
exposure. This suggests the possibility  that elevation happens in placenta with time. 
Therefore it might take longer for the level to be increased in the fetal brain, although Lasala 
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& Zhou (2007) detected elevated levels just 2 hours after injection. Thus both the day  of 
exposure and timing of exposure might be of significance. It is noted that Liverman et al. 
(2006) found that E18 injections of 50 μg LPS significantly  up regulated the brain levels of 
IL-1β after 6 hours of exposure, but no up regulation was seen before that (section 5.1). 
Furthermore concentrations used were smaller than in other studies, which indicate that 
timing of measurements after exposure is more important than the given dose. 
In contrast to Liverman et al. (2006), Graciarena et al. (2010) found increased production of 
IL-1β in brains of fetuses of dams exposed for 2 hours at E14. Considering that gestation 
days for both mice and rats are approximately  21 days, different exposure days may 
represent different stages in the pregnancy. Even though exposure only vary with 2 days. No 
studies have been found which specifically  examine the importance of exposure day. The 
results of Bäckström et al. (2010) indicates that an early  exposure (e.g. before E14) is 
effective, since the offspring is not fully  developed. E18 is late in the gestation period 
compared with this, yet this is the exposure day  chosen by  most studies. It would be 
interesting to see experiments which focus only  on time points, both prenatally  and 
postnatally.
It would be ideal if experiments used realistic doses in order to assess the actual risk of 
exposure. While it is difficult to evaluate whether or not the concentrations used in the 
presented experiments are realistic, it can also be argued that a high dose may  be required 
in order to achieve detectable effects. Furthermore, there is no guarantees that even smaller 
doses wonʼt have similar effects. 
Evaluating these studies it becomes evident that a lot of factors are adjustable, and might 
have an impact on the results. The concentrations of LPS/ IL-1β, the time and repetitions of 
exposure, the amount of time between exposure and death and animals used are variable 
factors. Besides these and other differences among the studies is the sort of injection, which 
in these studies were subcutaneous or intra peritoneally. The majority  of the studies used i.p. 
injections. Though, Hodyl et al. 2007 and Graciarena et al. (2010) used sc. injections and 
Bäckström et al. 2010 initiated production of IL-1β in rats through doxycycline in drinking 
water. There does not seem to be a pattern between the sort of injections and results, but 
again there are a lot of factors different between the studies.
According to Gilmore et al. (2004) (section 5.2) disturbance of dendrite development and 
development of cortical neurons, can be caused by elevated levels of IL-1β in vitro, at 1000 
U/ml. Marx et al. (2001) found similar results indicating the neuronal survival decreased in a 
dose dependent manner. Both the dose of 100 U/ml and 1000 U/ml decreased the number of 
neurons. The results of both Gilmore et al. (2004) and Marx et al. (2001 show that 1000 U/ml 
IL-1β on brain tissue can cause decreased neuronal survival and be harmful to the 
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development of dendrites and neurons. Both studies propose a link between these damages 
and an increased risk of schizophrenia [Marx et al. 2001], [Gilmore et al. 2004].
According to Bäckström et al. (2010) an increased IL-1β level could in some cases be 
advantageous. A prenatal exposure could decrease the immune response in newborns and 
make the infection less harmful. As mentioned many  unwanted effects is also associated with 
an elevated IL-1β level.
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Conclusion
Increased levels of prenatal IL-1β are associated with altered immune response in newborns 
and varies with the period of maternal exposure during pregnancy. Alterations in immune 
response of offspring might not be permanent. The level of IL-1β in the fetal brain is raised 
due to maternal inflammation. Correlations exist between elevated IL-1β levels in the brain 
and impaired dendrite and neuronal development and also an decreased number of neurons. 
Conclusively, there is evidence of causal relationships between an elevated level of IL-1β 
during pregnancy and both altered immune response and neural development of the fetus.
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